StockFin.ai
NewsScreensInsightsPricing
/
Sign inTry Free
SF
New ChatNewsInsightsScreenerPricing
Sign In
NewsScreensChatSign In

Tools

Search Companies
News & Filings
Insights & Articles
FeaturesComing Soon
Pricing
Home โ€บ 526409

KKalpana Industries (India) Ltd (526409)

Chemicals ยท Chemicals ยท NSE ยท Updated 29 September 2026
By StockFin Research Teamโ€ขAI-Assisted Analysisโ€ขSource: BSE/NSE Filings
โ‚น6.8โ†“ 42.03% (1Y)

๐ŸŽฏ Key Takeaways

  • KKalpana Industries (India) Ltd is a small-cap chemical manufacturer operating in a capital-intensive, cyclical sector, currently in a phase of persistent operational losses and declining profitability. The company has reported negative operating margins for four consecutive quarters, with a P/E ratio of 344 reflecting extreme earnings volatility and low investor confidence.
  • Revenue declined 16.3% QoQ to โ‚น16 in Q3FY24.
  • โš ๏ธ Persistent operational losses and negative EBITDA trends with no clear path to profitability.
Market Cap
โ‚น64
P/E Ratio
340.0
P/B Ratio
1.81
ROE
0.6%
ROCE
7.0%
Debt/Equity
1.31
Promoter
75.0%
โœจ Ask AI About 526409๐Ÿ“Š Interactive Charts

๐Ÿ“– The Story

KKalpana Industries (India) Ltd is a small-cap chemical manufacturer operating in a capital-intensive, cyclical sector, currently in a phase of persistent operational losses and declining profitability. The company has reported negative operating margins for four consecutive quarters, with a P/E ratio of 344 reflecting extreme earnings volatility and low investor confidence. Despite stable promoter holding at 75%, there is no institutional interest, and shareholder returns remain minimal. The business appears to be in a distressed or stagnant phase, with limited scale and pricing power in a competitive market.

๐Ÿ“ฐ What's Happening

The most recent filing activity includes the dispatch of letters to shareholders regarding access to the FY 2025-26 Annual Report and the notice for the 41st AGM scheduled on 26 September 2026, sent on 27 August 2026 to shareholders without registered email addresses. This administrative action underscores ongoing compliance obligations but reflects no strategic shift. There are no disclosed new capital projects, capacity expansions, or management changes in the recent filings. The company continues to operate with minimal institutional engagement, and no major M&A or restructuring announcements have been made in the latest disclosures.

Source: Stock Announcements

๐Ÿ“Š Quarterly Results (โ‚น Cr)

MetricMar 2023Jun 2023Sep 2023Dec 2023
Revenue17141916
Operating Profit-2-3-3-2
OPM %-13.8%-21.1%-18.3%-15.5%
Net Profit0-00-0
EPSโ‚น0.04โ‚น-0.02โ‚น0.00โ‚น0.00

The company has reported sequentially improving but still deeply negative operating margins, with OPM rising from -21.1% in Jun 2023 to -13.8% in Mar 2023, though revenue remains volatile between โ‚น14โ€“19 crore quarter-on-quarter. Despite modest revenue stability, net profits have fluctuated between small positive and negative values, with EPS turning from a loss of โ‚น0.02 in Jun 2023 to a gain of โ‚น0.04 in Mar 2023, suggesting temporary relief but no sustainable profitability. The lack of consistent earnings growth and persistent operational losses indicate that the company has not yet stabilized, and margin improvements may be tactical rather than structural.

๐Ÿ”ฎ Management Outlook & What's Next

There is no explicit forward guidance or strategic outlook provided in the latest annual report filing or quarterly results commentary. Management has not articulated a clear path to profitability, margin recovery, or revenue growth in the available disclosures. The absence of guidance on capital allocation, capacity utilization, or market expansion suggests either a lack of strategic clarity or deliberate restraint in public communication. Investors should note that no targets related to cost optimization, diversification, or margin improvement were highlighted in the recent filings.

Extracted from official company announcements. Not StockFin.ai's opinion.

๐Ÿฆ Balance Sheet (โ‚น Cr)

ItemMar 2022Mar 2023Mar 2023Mar 2024
Equity Capital19191919
Reserves15161516
Borrowings23465248
Total Liabilities72979296
Fixed Assets44344746
Investments21520
Total Assets72979296

The balance sheet shows stable equity of โ‚น19 crore over the past two years, with reserves growing slightly from โ‚น15 to โ‚น16 crore, indicating limited retained earnings. Borrowings have increased marginally from โ‚น46 to โ‚น48 crore, while total assets remain flat around โ‚น96โ€“97 crore, suggesting a capital-light but asset-constrained operation. There is no evidence of aggressive deleveraging or major asset sales, and the modest rise in borrowings may reflect working capital needs rather than expansion. The capital structure remains heavily reliant on debt, with a debt-to-equity ratio of 1.31, raising concerns about financial flexibility amid ongoing losses.

๐Ÿ’ฐ Cash Flow Statement (โ‚น Cr)

ItemMar 2023
Operating-4
Investing-6
Financing+21
Net Cash Flow+11

๐Ÿ‘ฅ Shareholding Pattern

CategoryQ2FY26Q3FY26Q4FY26Q1FY27
Promoters75.0%75.0%75.0%75.0%
FII0.0%0.0%0.0%0.0%
DII0.0%0.0%0.0%0.0%
Public20.5%20.4%20.5%20.6%
# Shareholders13,99113,49113,60413,890

Promoter holding remains steady at 75% across all recent quarters, indicating no dilution or stake sale. However, Foreign Institutional Investors (FII) and Domestic Institutional Investors (DII) hold zero stakes, and public shareholding has slightly declined from 20.53% to 20.37% over the last four quarters, with the number of public shareholders decreasing from 13,991 to 13,491. This lack of institutional accumulation and shrinking retail interest signals declining market confidence. There are no signs of activist activity or new investor interest, and the stock remains largely held by a stable but passive promoter group.

โš–๏ธ Peer Comparison โ€” Chemicals

CompanyMCap (โ‚น Cr)P/EROCEROED/E
PIDILITIND1.53 L Cr57.633.4%โ€”0.01
SRF73,81034.115.6%โ€”0.36
LINDEINDIA52,81496.717.5%โ€”0.00
FLUOROCHEM48,77479.79.6%โ€”0.34
NAVINFLUOR43,25654.722.2%โ€”0.31
GODREJIND36,15330.89.2%โ€”4.57
HSCL33,80742.020.7%โ€”0.16
AETHER23,02997.713.8%โ€”0.08
DEEPAKNTR21,15527.015.3%โ€”0.26
CASTROLIND19,89118.776.2%โ€”0.00

๐Ÿ”— Peer Stock Analyses

PIDILITINDSRFLINDEINDIAFLUOROCHEMNAVINFLUOR

โš ๏ธ Risk Factors

1. Persistent operational losses and negative EBITDA trends with no clear path to profitability. 2. High leverage (D/E of 1.31) combined with low profitability raises solvency concerns in a capital-intensive sector. 3. Complete absence of institutional ownership and declining public shareholding suggest limited investor confidence. 4. Management has not articulated any strategic transformation, cost restructuring, or diversification plan to address structural challenges in the chemical business.

๐Ÿ“‹ Recent Filings

  • ๐ŸŸก Board Meeting2026-09-28KKalpana Industries announced the appointment of Mrs. Deepika Bhutra as Company Secretary and Compliance Officer effective 1 October 2026, and nominatโ€ฆ
  • ๐ŸŸก Board Meeting2026-09-28KKalpana Industries announced that Mrs. Rajni Mishra was regularized as a Non-Executive Independent Director effective 1% July 2026 following approvalโ€ฆ
  • ๐Ÿ”ด Financial Results2026-09-28KKalpana Industries reported voting results from its 41st Annual General Meeting held on 26 September 2026, where shareholders approved the audited fiโ€ฆ
  • ๐ŸŸก Board Meeting2026-09-26Kkalpana Industries held its 41st AGM on 26 September 2026 via video conference, with 56 members representing 75.11% of paid-up capital attending. Chaโ€ฆ
  • Announcement2026-09-23Kkalpana Industries (India) Limited announced that its trading window for insider transactions will close effective 1 October 2026 and remain shut untโ€ฆ
  • ๐Ÿ”ด annual report2026-08-27Kkalpana Industries (India) Limited announced that letters with web links to access the Annual Report for FY 2025-26 and the Notice of its 41st AGM scโ€ฆ

๐Ÿง  Analyst's Read

KKalpana Industries remains a high-risk, low-visibility small-cap with no clear catalysts for recovery. Investors should monitor for any strategic shifts, margin improvement initiatives, or debt reduction plans, but current indicators suggest the company is not on a sustainable upward trajectory. The next directional move will likely be driven by macrochemical demand trends or a potential restructuring announcement, neither of which have been signaled to date.

Based on filing content and financial data. Not a recommendation.

Read the full analysis

Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights โ€” sign up free to unlock.

Sign Up Free โ€” Unlock Full Analysis

2 free AI queries per day.

โœจ Deep Dive with AI on 526409

Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only โ€” not investment advice. Updated 2026-09-29.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

๐Ÿ“ก Get AI alerts for your stocks โ€” summarized by AI daily

Set up your AI Radar โ€” pick stocks, get daily email summaries of new filings.

Set up AI Radar โ€” Free

Free account ยท 2 AI queries/day

ยฉ 2026 StockFin.ai is not a SEBI-registered advisor. For informational purposes only.

Data provided by CMOTS Internet Technologies Pvt Ltd

AboutPrivacy PolicyTerms of ServicePricing

Latest News

View all โ†’
PVR Inox Ltd

Promoter Sanjeev Kumar accepted 77,897 shares in PVR INOX buyback

29 SeptPVRINOX
Read more โ†’
PVR Inox Ltd

Promoter sells shares in company buyback

29 SeptPVRINOX
Read more โ†’
Coal India Ltd

Dr. Anjani Kumar appointed Director (Tech.) in Western Coalfields Limited

29 SeptCOALINDIA
Read more โ†’
Apollo Micro Systems Ltd

Company announces investor presentation for upcoming analyst meeting

29 SeptAPOLLO
Read more โ†’
IRB Infrastructure Developers Ltd

IRB InvIT Fund completes Rs.2,351Crs fund-raise through institutional placement and preferential allotment.

29 SeptIRB
Read more โ†’
Adani Enterprises Ltd

SEBI settlement order finalized for Adani Enterprises

29 SeptADANIENT
Read more โ†’
Adani Energy Solutions Ltd

SEBI settlement order finalized for Adani Energy Solutions

29 SeptADANIENSOL
Read more โ†’
Multi Commodity Exchange of India Ltd

MCX appoints Ramesh Varakhedkar as Chief Business Officer

29 SeptMCX
Read more โ†’
Adani Power Ltd

SEBI settlement order finalized for Adani Power and key directors

29 SeptADANIPOWER
Read more โ†’
Prime Focus Ltd

Prime Focus Limited released its Investor Presentation on September 29, 2026, detailing FY26 financials and strategic updates.

29 SeptPFOCUS
Read more โ†’
Adani Ports & Special Economic Zone Ltd

SEBI settlement order finalized for Adani Ports without admission of guilt

29 SeptADANIPORTS
Read more โ†’
IRB InvIT Fund

IRB InvIT Fund approved institutional placement of 317,460,316 units at โ‚น63 per unit raising โ‚น20,000 million.

29 SeptIRBINVIT
Read more โ†’
BLS International Services Ltd

BLS subsidiary approves sale of JLG financial lending business to TVAM

29 SeptBLS
Read more โ†’
BLS E-Services Ltd

ATPL to sell JLG financial lending business to TVAM via slump sale

29 SeptBLSE
Read more โ†’
Anupam Rasayan India Ltd

Anupam Rasayan completes 2.12% acquisition of Bliss GVS Pharma, achieving 47.95% total stake and promoter status.

28 SeptANURAS
Read more โ†’
Poonawalla Fincorp Ltd

CARE Ratings reaffirmed and upgraded Poonawalla Fincorp's debt facilities with stable outlooks

28 SeptPOONAWALLA
Read more โ†’
Ola Electric Mobility Ltd

Board approves constitution of Rights Issue Committee

28 SeptOLAELEC
Read more โ†’
Pakka Ltd

FIR registered for death of team member amid allegations against senior executives

28 SeptPAKKA
Read more โ†’
Go Digit General Insurance Ltd

Meeting convened to approve amalgamation scheme between Go Digit Infoworks and Go Digit General Insurance.

28 SeptGODIGIT
Read more โ†’
Prasol Chemicals Ltd

Prasol Chemicals posted Q1 FY27 results showing 36% revenue growth and 122% EBITDA surge post-IPO listing.

28 SeptPRASOLCHEM
Read more โ†’